3. BALANCE SHEET COMPONENTS (Tables)

3 Months Ended

Jul. 31, 2013

Notes to Financial Statements

Inventory

	July 31, 2013		April 30, 2013
Raw materials	$	28,779	$	28,779
Finished goods		70,157		70,425
	$	98,936	$	99,204

Other current assets

	July 31, 2013		April 30, 2013
R&D materials	$	106,573	$	159,892
Deferred cost of sales		52,500		-
Other		7,090		7,090
Dermacyte samples		3,428		3,428
	$	169,591	$	170,410

Property Plant and Equipment

	July 31, 2013			April 30, 2013
Laboratory equipment	$	768,252		$	768,252
Computer equipment and software		134,311			135,697
Office furniture and fixtures		130,192			130,192
		1,032,755			1,034,141
Less: Accumulated depreciation and amortization		(849,986	)		(828,752	)
	$	182,769		$	205,389

Accrued Liabilities

	July 31, 2013		April 30, 2013
Employee related	$	95,051	$	66,632
Convertible note interest payable		61,500		59,583
Government grant expenses		51,385		-
Deferred revenue		50,937		185,068
Restructuring liability		43,728		43,728
Other operating costs		16,715		19,865
Accrued settlement costs		-		500,000
	$	319,316	$	874,876

Other liabilities

	July 31, 2013			April 30, 2013
Net non-cancelable operating lease obligation	$	87,456		$	98,388
Less: current portion		(43,728	)		(43,728	)
Long-term portion of net non-cancelable operating lease obligation	$	43,728		$	54,660